Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
Selim Corbacioglu(University Hospital Regensburg), Simone Cesaro(University of Padua), Maura Faraci(Istituto Giannina Gaslini), Dominique Valteau‐Couanet(Institut Gustave Roussy), Bernd Gruhn(Jena University Hospital), Attilio Rovelli(University of Milano-Bicocca), Jaap Jan Boelens(University Medical Center Utrecht), Annette Hewitt(Great Ormond Street Hospital), Johanna Schrum(Universität Hamburg), Ansgar Schulz(University Hospital Ulm), Ingo Müller(University Children's Hospital Tübingen), Jerry Stein(Schneider Children's Medical Center), Robert Wynn(Royal Manchester Children's Hospital), Johann Greil(Heidelberg University), Karl-Walter Sykora(Medizinische Hochschule Hannover), Susanne Matthes‐Martin(St Anna Children's Hospital), Monika Führer, Anne O’Meara(Our Lady's Hospital), Jacek Toporski(Skåne University Hospital), Petr Sedláček(University Hospital in Motol), Paul G. Schlegel(Goethe University Frankfurt), Karoline Ehlert(University Hospital Münster), Anders Fasth(University of Gothenburg), Jacek Winiarski(Karolinska Institutet), Johan Arvidson(Uppsala University Hospital), Christine Mauz‐Körholz(Martin Luther University Halle-Wittenberg), Hulya Ozsahin, André Schrauder(University Hospital Schleswig-Holstein), Peter Bader(Goethe University Frankfurt), Joseph M. Massaro, Ralph B. D’Agostino, Margaret Hoyle, Massimo Iacobelli, Klaus‐Michael Debatin(University Hospital Ulm), Christina Peters(St Anna Children's Hospital), Giorgio Dini(Istituto Giannina Gaslini)
Cited by 375
Abstract
Related Papers
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
Jason Coppell, Paul G. Richardson, Robert J. Soiffer et al.|Biology of Blood and Marrow Transplantation|2009|594